Dongkook Pharmaceutical Launches Allergy Allergen Blocker 'Co&Tech'

[Asia Economy Reporter Seo So-jung] Dongkook Pharmaceutical (Vice Chairman Kwon Ki-beom) has launched the allergy-blocking ointment 'Co&Tech'. Co&Tech was developed in Europe and forms a protective film on the nasal mucosa to block substances that cause allergies.

Avoidance therapy, one of the treatment methods for allergic rhinitis, is the most basic treatment method for allergic rhinitis. It mainly involves avoiding allergy-causing substances in daily life, such as removing dust mites, improving air quality, and limiting pets.

However, simply avoiding allergy-causing substances in daily life is not sufficient, so in Europe, avoidance therapy agents have been developed to enhance this method and are used in treatment.

According to clinical research results on white soft paraffin, the ingredient of Co&Tech, using it four times a day for nine days improved nasal symptoms such as nasal congestion and runny nose by 75%, showing a significant effect compared to the placebo group (25% improvement).

In a clinical study where it was used three times a day for 30 days, the 'quality of life improvement' score, which is usually low in allergic rhinitis patients, was more than four times higher than that of the placebo group.

Co&Tech does not contain pigments or preservatives and can be used alongside existing treatments. It is effective for allergic rhinitis caused by pollen during seasonal changes or pet dog hair, and can also help prevent frequent nosebleeds caused by nasal dryness, which is common in chronic allergic rhinitis.

Co&Tech is an ointment-type product that, when applied to the nasal mucosa using fingers or cotton swabs, lasts for 3 to 5 hours and is naturally expelled, so there is no concern about absorption into the body, allowing for repeated use. It is available in two types?unscented and mint?in a tube form and is sold at pharmacies.

A marketing representative from Dongkook Pharmaceutical said, "Since 35% of people with allergic rhinitis do not treat it and leave it untreated, we plan to actively promote the need for future management."